TY - JOUR
T1 - Fate of the unoperated ascending thoracic aortic aneurysm
T2 - three-decade experience from the Aortic Institute at Yale University
AU - Wu, Jinlin
AU - Zafar, Mohammad A.
AU - Liu, Yiwei
AU - Chen, Julia Fayanne
AU - Li, Yupeng
AU - Ziganshin, Bulat A.
AU - Ellauzi, Hesham
AU - Mukherjee, Sandip K.
AU - Rizzo, John A.
AU - Elefteriades, John A.
N1 - Publisher Copyright:
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved.
PY - 2023/11/14
Y1 - 2023/11/14
N2 - Aims This study aims to outline the ‘true’ natural history of ascending thoracic aortic aneurysm (ATAA) based on a cohort of patients not undergoing surgical intervention. Methods and results The outcomes, risk factors, and growth rates of 964 unoperated ATAA patients were investigated, over a median follow-up of 7.9 (maximum of 34) years. The primary endpoint was adverse aortic events (AAE), including dissection, rupture, and aortic death. At aortic sizes of 3.5–3.9, 4.0–4.4, 4.5–4.9, 5.0–5.4, 5.5–5.9, and ≥6.0 cm, the average yearly risk of AAE was 0.2%, 0.2%, 0.3%, 1.4%, 2.0%, and 3.5%, respectively (P < 0.001), and the 10-year survival free from AAE was 97.8%, 98.2%, 97.3%, 84.6%, 80.4%, and 70.9%, respectively (P < 0.001). The risk of AAE was relatively flat until 5 cm of aortic size, at which it began to increase rapidly (P for non-linearity <0.001). The mean annual growth rate was estimated to be 0.10 ± 0.01 cm/year. Ascending thoracic aortic aneurysms grew in a very slow manner, and aortic growth over 0.2 cm/year was rarely seen. Multivariable Cox regression identified aortic size [hazard ratio (HR): 1.78, 95% confidence interval (CI): 1.50–2.11, P < 0.001] and age (HR: 1.02, 95% CI: 1.00–1.05, P = 0.015) as significant independent risk factors for AAE. Interestingly, hyperlipidemia (HR: 0.46, 95% CI: 0.23–0.91, P = 0.025) was found to be a significant protective factor for AAE in univariable Cox regression. Conclusion An aortic size of 5 cm, rather than 5.5 cm, may be a more appropriate intervention criterion for prophylactic ATAA repair. Aortic growth may not be an applicable indicator for intervention.
AB - Aims This study aims to outline the ‘true’ natural history of ascending thoracic aortic aneurysm (ATAA) based on a cohort of patients not undergoing surgical intervention. Methods and results The outcomes, risk factors, and growth rates of 964 unoperated ATAA patients were investigated, over a median follow-up of 7.9 (maximum of 34) years. The primary endpoint was adverse aortic events (AAE), including dissection, rupture, and aortic death. At aortic sizes of 3.5–3.9, 4.0–4.4, 4.5–4.9, 5.0–5.4, 5.5–5.9, and ≥6.0 cm, the average yearly risk of AAE was 0.2%, 0.2%, 0.3%, 1.4%, 2.0%, and 3.5%, respectively (P < 0.001), and the 10-year survival free from AAE was 97.8%, 98.2%, 97.3%, 84.6%, 80.4%, and 70.9%, respectively (P < 0.001). The risk of AAE was relatively flat until 5 cm of aortic size, at which it began to increase rapidly (P for non-linearity <0.001). The mean annual growth rate was estimated to be 0.10 ± 0.01 cm/year. Ascending thoracic aortic aneurysms grew in a very slow manner, and aortic growth over 0.2 cm/year was rarely seen. Multivariable Cox regression identified aortic size [hazard ratio (HR): 1.78, 95% confidence interval (CI): 1.50–2.11, P < 0.001] and age (HR: 1.02, 95% CI: 1.00–1.05, P = 0.015) as significant independent risk factors for AAE. Interestingly, hyperlipidemia (HR: 0.46, 95% CI: 0.23–0.91, P = 0.025) was found to be a significant protective factor for AAE in univariable Cox regression. Conclusion An aortic size of 5 cm, rather than 5.5 cm, may be a more appropriate intervention criterion for prophylactic ATAA repair. Aortic growth may not be an applicable indicator for intervention.
UR - https://www.scopus.com/pages/publications/85163854148
UR - https://www.scopus.com/pages/publications/85163854148#tab=citedBy
U2 - 10.1093/eurheartj/ehad148
DO - 10.1093/eurheartj/ehad148
M3 - Article
C2 - 36994934
AN - SCOPUS:85163854148
SN - 0195-668X
VL - 44
SP - 4579
EP - 4588
JO - European Heart Journal
JF - European Heart Journal
IS - 43
ER -